https://www.selleckchem.com/products/bufalin.html
The modulation initiated by BO represents a promising strategy for treatment of obesity and related metabolic diseases.Non-healing diabetic foot ulcers (DFUs) are a serious complication in diabetic patients. Their incidence has increased in recent years. Although there are several treatments for DFUs, they are often not effective enough to avoid amputation. Protein tyrosine phosphatase 1B (PTP1 is expressed in most tissues and is a negative regulator of important metabolic pathways. PTP1B is overexpressed in tissues under diabetic con
Like
Comment
Share
